approval
savePOLIVY (POLATUZUMAB VEDOTIN-PIIQ) — FDA approval
community read0 votes
Sponsor: GENENTECH. Form: POWDER. Route: INTRAVENOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
drug timeline · 3
same company · ±60 days · 6
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalJun 11, 2019
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalJun 11, 2019
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalMay 6, 2019
- approvalatezolizumab: TECENTRIQ (ATEZOLIZUMAB) — FDA approvalMay 6, 2019
- approvaltrastuzumab emtansine: KADCYLA (ADO-TRASTUZUMAB EMTANSINE) — FDA approvalMay 3, 2019
- approvaltocilizumab: ACTEMRA (TOCILIZUMAB) — FDA approvalApr 11, 2019
comments(0)
5-min edit window · permanent after that